Comprehensive Human NAT2 Genotype Method Using Single Nucleotide Polymorphism-Specific Polymerase Chain Reaction Primers and Fluorogenic Probes

This publication has 13 references indexed in Scilit:

• Novel Human N-Acetyltransferase 2 Alleles That Differ in Mechanism for Slow Acetylator Phenotype
  Published by Elsevier ,1999
• Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
  Science, 1999
• Determination of Human NAT2 Acetylator Genotype by Oligonucleotide Ligation Assay
  BioTechniques, 1997
• A new mutation C759T in the polymorphic N-acetyltransferase (NAT2) gene
  Pharmacogenetics, 1997
• Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population
  Clinical Pharmacology & Therapeutics, 1996
• Determination of HumanNAT2Acetylator Genotype by Restriction Fragment-Length Polymorphism and Allele-Specific Amplification
  Analytical Biochemistry, 1995
• Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene
  Pharmacogenetics, 1994
• SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
  Carcinogenesis: Integrative Cancer Research, 1993
• Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
  Proceedings of the National Academy of Sciences, 1991
• Molecular mechanism of slow acetylation of drugs and carcinogens in humans.
  Proceedings of the National Academy of Sciences, 1991